Specialist Clinical Documentation Assessment

PHQ-9 score, risk stratification, protective factors, and safety plan captured in full. Suicidal ideation documented with appropriate clinical language. Minor verbosity deduction in the Plan section.

Psychiatric content accurate. Stated protective factors — family support and future orientation — not recorded in this evaluation. Scored under completeness criterion.

Safety plan partially transcribed with two action steps not captured. Scored under completeness and safety netting criteria. Higher use of bullet subheadings noted.

Ann Arbor staging, LDH levels, ECOG performance status, and proposed R-CHOP regimen documented with full precision. Consent discussion and fertility preservation counselling both captured. Minor extra inference noted under criterion 6.

Staging documentation accurate. Patient's expressed preference to delay treatment pending a second opinion not recorded in this evaluation. Scored under completeness criterion.

Possible Hodgkin lymphoma included as an alternative consideration; pathology had already confirmed non-Hodgkin subtype. Scored under criterion 6. Higher verbosity across sections noted.

Timed Up and Go result, Beers Criteria medications flagged, and deprescribing recommendations captured. MMSE score and carer input accurately documented. Minor drug name abbreviation deduction.

Metoprolol transcribed as metolazone in this evaluation. Affected scores under criteria 2, 8, and 9, resulting in a Not Safe for Clinical Use classification for this domain.

Clinician's recommendation to cease mirtazapine not recorded in this evaluation. Scored under completeness criterion (criterion 7).

Peripheral neuropathy grading, PICC line status, and surveillance imaging plan documented accurately. Hormone receptor status and adjuvant endocrine therapy recorded precisely. Minor conciseness note only.

Clinical content accurate and well-structured. CTCAE Grade 2 fatigue not documented in this evaluation. Scored under completeness criterion.

Anastrozole 1 mg daily transcribed as 10 mg daily in this evaluation. Scored under STT error correction criterion (criterion 8).

Antipsychotic risk discussion, carer burden assessment, and non-pharmacological strategies captured accurately. Capacity assessment outcome and substitute decision-maker documented.

Documentation accurate overall. Carer's concern about the patient's nighttime wandering behaviour not recorded in this evaluation. Scored under completeness criterion.

Possible Lewy body dementia included as a consideration; not raised during the consultation. Scored under criterion 6. Lower conciseness scores across subsections.